Why smart founders still get this fundraising decision wrong — and the simple framework that fixes it before you sign anything

SAFE note vs convertible note. If you’ve typed that exact phrase into Google at 1 a.m. with a term sheet open in another tab, you’re not alone, and you’re not behind. I’ve sat on both sides of this decision more times than I can count — first as a founder raising my own seed rounds, later as an angel and now as a fund manager writing checks into early-stage companies. And here’s the thing nobody tells first-time founders: this isn’t really a legal question. It’s a math question wearing a legal costume. Get the math wrong, and you can hand away 15–20% more of your company than you needed to, without a single “villain” investor doing anything malicious. The instrument itself just quietly worked against you.

This guide is the one I wish someone had handed me before my first raise. No jargon for jargon’s sake, no filler, just the real mechanics of how a SAFE note and a convertible note actually behave on your cap table, backed by current 2026 market data, and a decision framework you can use today.

What Is a SAFE Note? The Founder-Friendly Default in 2026

A SAFE note (Simple Agreement for Future Equity) is not debt. It’s a contract that gives an investor the right to receive equity later, usually when you raise your next priced round. Y Combinator’s then-general counsel Carolynn Levy created the instrument in 2013 specifically to replace the slow, expensive convertible notes that were bogging down early fundraising. No interest accrues. No maturity date forces a repayment conversation. No debt sits on your balance sheet scaring off your next lender or acquirer.

That simplicity is exactly why, in the SAFE note vs convertible note debate, the SAFE has become the overwhelming default for US pre-seed and seed rounds. It’s shorter (the standard YC form runs about five pages), it’s cheaper to paper (often $0–$1,500 in legal fees versus several thousand for a note), and it closes in days instead of weeks.

How a Post-Money SAFE Actually Works

In 2018, YC rewrote the original instrument into what’s now called the post-money SAFE, and this single change is the most misunderstood part of the SAFE note vs convertible note comparison. Here’s the mechanic in plain English: a post-money SAFE’s valuation cap includes all outstanding SAFE money in the denominator, which means your investor’s ownership percentage is locked in the moment they sign, no matter how many more SAFEs you issue afterward. A $500,000 investment on a $5,000,000 post-money cap is 10% — full stop, guaranteed, regardless of what else happens on your cap table before the priced round.

The catch, and it’s a big one: every additional SAFE you stack on top of that first one dilutes you, the founder, not your earlier SAFE holders. Under the old pre-money structure, new SAFEs diluted everyone proportionally. Under the post-money structure, founders absorb all of it until the priced round finally happens. This is exactly why tracking cumulative SAFE ownership before you raise your priced round isn’t optional anymore — it’s survival math.

The Three Official YC SAFE Templates

Y Combinator publishes three standard post-money SAFE forms, all available free at ycombinator.com/documents: a valuation-cap-only version, a discount-only version, and an MFN (Most Favored Nation) version with neither a cap nor a discount, which simply guarantees the investor gets the best terms given to any later SAFE investor. YC’s own standard deal to every accepted company is, in fact, two SAFEs stapled together: $125,000 for a fixed 7% and $375,000 uncapped with an MFN clause — a useful real-world benchmark for how these instruments get combined in practice.

What Is a Convertible Note? The Original Bridge-Financing Tool

A convertible note predates the SAFE and is, structurally, a loan. When an investor writes you a check via a convertible note, the startup signs a promissory note that includes a principal amount, an interest rate, and a maturity date. Like a SAFE, the note is designed to convert into equity — usually preferred stock — at your next qualified financing round, and it typically converts at a discount to what new investors pay, capped by a maximum valuation.

The core distinction in the SAFE note vs convertible note conversation comes down to one word: debt. A convertible note is debt on your balance sheet. If your company never raises another round and never gets acquired, that note technically comes due, and your investor has a legal right to demand repayment in cash — principal plus accrued interest.

Interest, Maturity, and Why Notes Behave Differently

Convertible notes generally accrue simple interest in the 4–8% range, with 5–6% being the most common band in the current market, and that interest compounds into the eventual share count at conversion rather than being paid out in cash along the way. Maturity dates typically run 18–24 months, sometimes extending to 36 months for later-stage bridge notes. When that maturity date approaches without a triggering round, founders and investors usually renegotiate — extending the note, converting it at the existing cap regardless of a priced round, or, in the worst case, facing a real repayment demand the company can’t meet. That legal exposure, however rarely enforced, is precisely the “downside protection” that makes some investors prefer notes over SAFEs, and it’s why convertible notes still show up in specific situations: bridge rounds between existing investors, biotech and hardware startups with long R&D runways before their next raise, and jurisdictions or investor bases less familiar with the SAFE structure.

SAFE Note vs Convertible Note: The Core Differences at a Glance

Feature	SAFE Note	Convertible Note
Legal classification	Equity-like contract, not debt	Debt instrument (a loan)
Interest	None	Typically 4–8% simple interest
Maturity date	None — no forced repayment	Yes, typically 18–24 months
Conversion trigger	Next priced round (or acquisition/dissolution)	Qualified financing, maturity, or acquisition
Valuation cap	Common, negotiable	Common, negotiable
Discount rate	Common, typically 10–20%	Common, typically 15–25%
Balance sheet impact	No liability recorded	Recorded as a liability
Legal cost to paper	Low ($0–$3,000)	Moderate ($3,000–$10,000+)
Time to close	Days	Days to a few weeks
Investor downside protection	Lower — no repayment right	Higher — legal repayment right at maturity
US pre-seed market share, Q1 2026	~93% of instruments	~7% of instruments

That last row matters more than most founders realize, and it’s worth sitting with for a second: according to Carta’s Q1 2026 State of Pre-Seed report, convertible notes fell to a record-low 7% of pre-seed rounds and just 8% of pre-seed dollars, with SAFEs now the default financing instrument for early-stage US startups by a wide margin.

SAFE Note vs Convertible Note: A Real Dilution Math Example

Numbers convince founders faster than paragraphs, so let’s walk through one.

Scenario A — Post-money SAFE. Your startup, Nova, raises $750,000 on a post-money SAFE with an $8,000,000 valuation cap. Your investor’s eventual ownership is fixed the day they sign: $750,000 ÷ $8,000,000 = 9.375%. Three months later, you raise an additional $500,000 SAFE from a new angel at a $10,000,000 cap: $500,000 ÷ $10,000,000 = 5%. Your combined SAFE holders now own roughly 14.4% of the company before you’ve even priced a round — and because these are post-money SAFEs, that 14.4% comes directly out of the founders’ side of the table, not out of each other’s. When you eventually raise your priced Series Seed at, say, a $14,000,000 pre-money valuation with a standard 10% post-closing option pool, that pool and the new investor’s shares carve further into what’s left of founder ownership. Model it before you sign the second SAFE, not after.

Scenario B — Convertible note, same amount raised. Nova instead raises the same $750,000 via a convertible note with a 20% discount and the same $8,000,000 cap, at 6% simple annual interest. Eighteen months pass before the priced round closes. That interest accrues to roughly $67,500, lifting the effective conversion amount to about $817,500. At conversion, the note holder gets whichever is more favorable to them — the discounted price per share or the capped price per share — applied to that larger, interest-inflated principal. The founder doesn’t just give up equity for the original $750,000; they give up equity for the $750,000 plus eighteen months of accruing interest, and they’ve also carried real legal repayment exposure the entire time the note sat outstanding.

Neither instrument is “cheaper” in every scenario — the SAFE trades interest accrual for founder-absorbed stacking dilution, while the note trades debt exposure for investor-favorable interest math. The right answer depends entirely on your specific stacking behavior and time-to-next-round, which is exactly why a spreadsheet, not a gut feeling, should make this call.

Negotiating a SAFE Note or Convertible Note: The Terms That Actually Matter

Most first-time founders spend their negotiating energy on the wrong line item. The headline number — the valuation cap — gets all the attention, but three quieter terms usually move more equity in practice.

Valuation cap. This sets the maximum price at which the instrument converts, protecting the investor if your company’s value jumps before the priced round. A lower cap means more shares for the same investment dollar, so investors push it down and founders push it up. Benchmark yours against comparable rounds in your sector and geography rather than picking a number that “feels right” — a cap wildly out of line with market comps either signals inexperience to sophisticated investors or quietly overprices you for your next round.

Discount rate. This gives the investor a percentage off whatever price per share your next priced round sets, typically 10–20% on SAFEs and 15–25% on convertible notes. A discount only matters when it produces a better price than the cap does — the instrument converts at whichever is more favorable to the investor, so model both, not just one.

MFN (Most Favored Nation) clauses. An MFN provision means that if you later give a different investor better terms — a lower cap, a bigger discount — your MFN investor automatically gets upgraded to match. This is common on uncapped SAFEs and can quietly compound if you’re not tracking every instrument’s terms side by side. Before adding a fourth or fifth uncapped MFN SAFE to your stack, model what happens if your next investor negotiates a meaningfully lower cap than everyone before them.

Pro-rata rights. Investors putting in more than roughly $100,000 on a SAFE frequently ask for a pro-rata side letter, giving them the right (not the obligation) to invest enough in your next priced round to maintain their ownership percentage. This doesn’t cost you anything at signing, but it does commit a slice of your next round’s allocation, which matters if you’re trying to bring in a specific new lead investor who wants a meaningful stake.

None of these four terms is inherently good or bad for founders — they’re levers, and understanding which one is actually driving your dilution in a given deal lets you negotiate the term that matters instead of the one that’s loudest.

When Founders Should Use a SAFE Note

Reach for a SAFE note when speed and simplicity matter more than anything else — which, for most pre-seed and seed founders, is almost always. A SAFE makes sense when you’re a Delaware C-corp raising under roughly $3–4 million total, when your investor base is used to the instrument (most US angels and seed funds are, at this point), when you want to close checks the moment they’re ready instead of batching a formal round, and when you don’t want debt sitting on your books while you’re trying to close enterprise contracts or apply for venture debt later. If you’re stacking multiple SAFEs across several months, build a simple ownership-tracking sheet from day one — this is the single habit that separates founders who get blindsided at their priced round from founders who don’t.

When a Convertible Note Still Makes Sense

A convertible note earns its place in a handful of real situations. Insider bridge rounds — where existing investors are extending runway between a current round and an anticipated near-term priced round — often use notes because the debt structure gives investors clearer priority if things go sideways. Biotech, medtech, and hardware startups with multi-year R&D timelines before their next institutional raise sometimes prefer notes for the same reason. International rounds, where local counsel or investors are simply more familiar with debt-convertible structures than the SAFE, are another common case. And if an investor explicitly asks for downside protection as a condition of writing the check, a convertible note — not a fight over the instrument — is often the faster path to a closed round.

2026 Market Data: What Founders Are Actually Signing Right Now

The market has moved further toward SAFEs than most founders assume, and the direction has been consistent for years, not a one-quarter blip. Across 2021–2025, post-money SAFEs grew from just over 60% to nearly 90% of all SAFEs signed, while convertible notes have shrunk into a genuinely niche tool used mostly outside of standard software seed rounds. Pre-seed valuation caps have climbed alongside this shift: Carta’s Q2 2026 data shows that on larger pre-seed SAFEs (above $2.5 million), caps at the 90th percentile can now reach as high as $100 million, a trend concentrated heavily in AI companies, which captured roughly 48.6% of all pre-seed dollars in the first half of 2026. Meanwhile, the broader financing environment has gotten friendlier to founders on the dilution side: median dilution across seed-through-Series-C rounds fell from about 18% to 16% over the past year, and down rounds — once a real fear after the 2022–2023 reset — dropped from a 22% peak in 2023 to below 12% by early 2026. None of that changes the core SAFE note vs convertible note mechanics, but it does mean the terms you should expect to see and negotiate in 2026 look meaningfully different from what a founder raising in 2022 experienced.

5 Mistakes Founders Make With SAFE Notes and Convertible Notes

1. Stacking SAFEs without modeling cumulative dilution. Because post-money SAFEs dilute founders — not each other — every additional SAFE quietly eats into your ownership. Rebuild your “fully diluted if converted” cap table every time you add a new SAFE, not just before your priced round.

2. Treating a valuation cap as your company’s actual valuation. A $15 million cap is a ceiling for conversion math, not a market valuation you can repeat to press or future investors. Confusing the two sets false expectations that come back to bite you at your priced round.

3. Ignoring a convertible note’s maturity date. Founders routinely treat the maturity date as a formality that will “just get extended.” Sometimes it doesn’t, and a technically-due debt obligation during a cash crunch is a genuinely dangerous place to be. Calendar it and start the renegotiation conversation early.

4. Mixing pre-money and post-money SAFEs on one cap table. Older pre-money SAFEs and newer post-money SAFEs calculate dilution differently, and blending them without careful reconciliation creates ownership ambiguity that surfaces — painfully — at your next priced round.

5. Defaulting to a convertible note out of habit. Some law firms still default clients to convertible notes simply because that’s the template they’ve always used, even when a SAFE would close faster and cheaper for a straightforward pre-seed raise. Ask directly why a note is being proposed over a SAFE, and make sure the answer is about your deal, not your lawyer’s muscle memory.

Legal and Tax Considerations Every Founder Should Know

A few technical points get overlooked in the SAFE note vs convertible note conversation, and they’re expensive to learn about after the fact.

Section 83(b) elections. If you or any early team member receives restricted stock subject to vesting — including stock issued upon a SAFE or note conversion in some structures — filing a Section 83(b) election within 30 days of the transfer can meaningfully reduce future tax liability. The IRS introduced a standardized Form 15620 for these elections and now allows them to be filed online through an IRS account, a genuine process improvement worth knowing about if you’re issuing or receiving restricted shares in 2026.

Original Issue Discount (OID). This mostly applies to convertible notes issued alongside warrants. When a note and a warrant are sold as a package, the purchase price has to be allocated between them by fair market value for tax purposes, and the resulting gap between the note’s face value and its allocated issue price becomes OID — taxable to the holder as it accrues, even though no cash changes hands until conversion or repayment.

QSBS holding period. Qualified Small Business Stock treatment under Section 1202 can shelter a significant amount of gain on eventual sale, but the five-year holding period clock starts when the SAFE or note actually converts into stock — not on the day the investor wrote the check. Founders and early investors who assume their holding period started at initial funding sometimes discover, at exit, that they’re short of the threshold. This is worth confirming with a tax advisor well before any sale process begins.

Balance sheet and debt covenants. Because convertible notes are recorded as liabilities, they can complicate later venture debt facilities or affect covenants tied to your balance sheet in ways a SAFE simply doesn’t. If you’re planning to raise venture debt in the next 12–18 months, factor that into your instrument choice now.

None of the above is a substitute for advice from your own startup attorney or CPA — it’s context to bring into that conversation better prepared.

SAFE Note vs Convertible Note: A Simple Decision Framework

If you want one rule of thumb: default to a SAFE for a US Delaware C-corp pre-seed or seed round under roughly $3–4 million, and reach for a convertible note only when one of these applies — you’re raising an insider bridge ahead of an already-anticipated priced round, you’re in biotech, hardware, or another long-R&D-cycle sector where notes remain common, your investor explicitly requires debt-style downside protection as a condition of the check, or you’re closing with investors in a market where notes are simply the more familiar, faster-to-close instrument. Outside those four situations, the SAFE note vs convertible note choice isn’t close — the data, the legal cost, and the closing speed all point the same direction in 2026.

Questions to Ask Your Startup Lawyer Before You Sign

Whichever way the SAFE note vs convertible note decision lands, walk into that conversation with your counsel armed with specifics, not just “does this look okay?” Ask directly: What’s my fully diluted ownership if every outstanding SAFE or note converts today, at today’s terms? If this is a convertible note, what actually happens — contractually — if we hit the maturity date without a qualifying round? Is this a pre-money or post-money SAFE, and if we have both types outstanding, how do they interact at conversion? Does this instrument include an MFN clause, and if so, what triggers it? And finally, given our sector, stage, and the amount we’re raising, why is this the recommended instrument over the alternative — SAFE or note — rather than just the firm’s default template? A good startup attorney will have sharp, specific answers to every one of these in under five minutes. If they don’t, that’s worth noticing.

Frequently Asked Questions About SAFE Notes vs Convertible Notes

Is a SAFE note better than a convertible note? For most US pre-seed and seed founders raising under $3–4 million, a SAFE is faster, cheaper to paper, and doesn’t carry debt or a maturity deadline — which is why it now dominates the market. A convertible note remains the better tool for insider bridge rounds, certain long-R&D sectors, or when an investor specifically wants debt-style protection.

Do SAFE notes accrue interest? No. That’s one of the defining differences in the SAFE note vs convertible note comparison — SAFEs have no interest and no maturity date, while convertible notes typically accrue 4–8% simple interest until conversion or repayment.

What happens if a SAFE never converts? If your company never raises a priced round or gets acquired, a SAFE simply sits outstanding indefinitely — there’s no maturity date forcing repayment or renegotiation. It converts upon a triggering event (typically a priced equity round, acquisition, or dissolution) or not at all.

Can founders negotiate SAFE terms? Yes. While the YC templates are widely used as-is, the valuation cap, discount rate, whether an MFN clause applies, and pro-rata rights are all genuinely negotiable, especially outside of accelerator-standard deals.

What’s a typical valuation cap for a pre-seed SAFE in 2026? Caps vary widely by sector and traction, but 2026 pre-seed caps commonly fall in the $3–8 million range for standard rounds, climbing toward $10 million and above for AI-focused startups with early traction, and reaching as high as $100 million at the top end for larger, more competitive pre-seed rounds.

Is a SAFE note dilutive? Yes — despite the name, a SAFE is not “safe” from dilution. Under the post-money structure, every SAFE you issue dilutes founders specifically, which is exactly why tracking cumulative SAFE ownership before your priced round matters so much.

What’s the difference between a pre-money and post-money SAFE? A pre-money SAFE calculates ownership before including other outstanding SAFEs, which means multiple SAFE holders dilute each other unpredictably at conversion. A post-money SAFE, the current YC standard since 2018, locks in each investor’s ownership percentage at signing and shifts all subsequent dilution onto the founders instead.

How much does it cost to set up a SAFE note versus a convertible note? A standard SAFE, using the YC templates as-is, often costs little to nothing in legal fees if you and your investor both use the standard form without material changes. A convertible note typically runs $3,000–$10,000 or more in legal fees because it involves more negotiated debt terms — interest rate, maturity, repayment mechanics — that benefit from closer legal review on both sides.

Do I need a lawyer to issue a SAFE note? Technically you can use the free YC templates without one, and many founders do for small, standard checks. But it’s genuinely worth at least a short paid consultation with a startup attorney before your first raise — confirming your cap table math, your Delaware C-corp structure, and your 83(b) timing is far cheaper than fixing a mistake after the fact.

The Bottom Line

The SAFE note vs convertible note decision isn’t about which document sounds more sophisticated or which one your friend’s startup used. It’s a math decision with real, compounding consequences for how much of your own company you’ll own by the time you reach a priced round. In 2026, the data is about as clear as fundraising data gets: SAFEs dominate the market for good reason — speed, cost, and founder-friendly mechanics — while convertible notes still earn their place in a narrower set of real situations. Model both before you sign anything, track your cumulative dilution every time you add a new instrument, and don’t let a template someone else defaults to make this decision for you.

SAFE Note vs Convertible Note: The Brutal Truth That Could Cost You 20% of Your Company in 2026

Must read